Compare FEMY & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEMY | COSM |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0M | 12.9M |
| IPO Year | 2021 | 2009 |
| Metric | FEMY | COSM |
|---|---|---|
| Price | $2.66 | $0.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | 43.3K | ★ 5.1M |
| Earning Date | 05-08-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 44.71 | ★ 46.15 |
| EPS | ★ N/A | N/A |
| Revenue | $2,293,313.00 | ★ $65,271,815.00 |
| Revenue This Year | $105.16 | $54.08 |
| Revenue Next Year | $200.23 | $32.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 40.77 | 19.93 |
| 52 Week Low | $0.29 | $0.16 |
| 52 Week High | $6.29 | $1.32 |
| Indicator | FEMY | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 44.90 | 49.52 |
| Support Level | $2.77 | $0.17 |
| Resistance Level | $4.22 | $0.28 |
| Average True Range (ATR) | 0.39 | 0.02 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 19.62 | 71.47 |
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.